Plenus™ | 60 & 120 capsules
Plenus is an advanced satiety product to address overeating and weight loss. It represents the forefront of satiety research by addressing hunger through several distinct pathways, including gastric messaging to the brain, neural catecholamine function, hypothalamic hunger areas, and fatty acid synthesis.

Plenus is free of stimulants such as methylxanthines (caffeine, theophylline, theobromine, etc.), as well as any hidden botanical or other source of ephedrine and synephrine. Plenus utilizes dosages of ingredients used in clinical studies.

*use only under direct supervision of a licensed healthcare provider

Plenus™ is an advanced satiety formula to address overeating and weight loss. It represents the forefront of satiety research by addressing hunger through several distinct pathways, including gastric messaging to the brain, neural catecholamine function, hypothalamic hunger areas, and fatty acid synthesis.

Plenus™ is free of stimulants such as methylxanthines (caffeine, theophylline, theobromine, etc.), as well as any hidden botanical or other source of ephedrine and synephrine.

GarCitrin™: Garcinia cambogia, also known as Brindall Berry, standardized for 50% hydroxycitric acids and 5% garcinol as a Ca salt, has been demonstrated to control appetite and contribute to weight loss.

Slimaluma™: Caralluma fimbriata, standardized for 25% pregnene glycosides and 10% saponins, is a succulent from India closely related to Hoodia gordonii. Studies demonstrate appetite suppression/satiety; proposed MOA is via the hypothalamus.

Slendesta™: Standardized extract of PI 2, standardized for 5% proteinase PI 2 inhibitors. Significantly increases levels of cholecystokinin (CCK), a peptide that decreases gastric emptying and thus promotes satiety.

Phenylethylamine (PEA): This metabolite of D-phenylalanine stimulates Dopamine release in the mesolimbic “pleasure centers,” associated with loss of appetite.

NDB™: Nutrient Delivery Blend, optimizing gut absorption.

Suggested during neuroendocrine balancing when appetite and weight issues are indicated on the patient symptom survey. In metabolic syndrome, patients with insulin resistance often have disordered appetite control with imbalanced dopamine, serotonin, and/or low adrenal function.

In attempting to bring these patients back into neuro-endocrine balance, support of serotonin levels to help control carbohydrate cravings, using Plenus™ to support appetite control and to possibly help increase lean body mass, and implementing an insulin-sparing diet can be beneficial strategies.

A complete Healthy Weight Management program may require Prolent™, Lentra™, Procite-D™ and/or Adaptacin™, depending on the patient’s individual biochemical needs

No specific contraindications known other than for individuals who are hypersensitive to any of the Plenus ingredients.

Featured Ingredients

Garcinia Cambogia

Garcinia Cambogia Fruit

Caralluma Fimbriata

Bioperine®

The Natural Process

Slendesta®: The active constituent in Slendesta® is a special protein called Proteinase Inhibitor II (PI2). The PI2 in Slendesta works by promoting and extending the body’s natural release of cholecystoskinin (CCK), a powerful peptide that signals certain organs, including the stomach and brain, to induce feelings of fullness and satiety.

Without any of the unpleasant side effects such as jitters or bloating, Slendesta® promotes natural hunger management that allows people to stay on track and achieve their weight management goals.

Slimaluma®: Slimaluma® is Gencor’s proprietary and patented Caralluma Fimbriata extract. Caralluma Fimbriata is a cactus-like plant with long-standing use as food in India. The cactus was often eaten by local tribes-people to ward off hunger while hunting in the forests.  Its appetite suppressing qualities make it an ideal addition to modern diets. Gencor has developed a patented process for extracting the key constituents of the whole plant associated with appetite suppression and healthy weight management without chemically altering those constituents. This process has allowed Gencor to develop an effective, safe, an easy-to-use ingredient that helps adults of all ages maintain a healthy weight with diet and exercise.*

Recent studies involving Caralluma Fimbriata:

A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial. (source)

Caralluma Fimbriata Supplementation Improves the Appetite Behavior of Children and Adolescents with Prader-Willi Syndrome. (source)

On reviewing the studies undertaken on the chemistry, pharmacology, and therapeutic potential of Caralluma, it is concluded that the genus is also composed of pregnane glycosides as one of the major constituents. Availability of pregnane glycosides in Caralluma is an indication of the appetite-suppressant property of this genus. This coupled with the GRAS status of the extract of C. fimbriata has opened the possibility of developing an anti-obesity/appetite-suppressant product from other species of Caralluma. (source)